MGX Competitors & Alternatives
Compare Metagenomi, Inc. Common Stock with similar stocks in the same industry
Biotechnology
MGX
Main Stock$1.20
Tradestie Score
45
Market Cap
$89.70M
Revenue Growth
-0.7%
Analyst Upside
+569.5%
Top Competitors
221 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 53 | Compare |
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$8.62
|
$211.22M | - | 56 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$4.87
|
$202.58M | - | 56 | Compare |
|
GUTS
Fractyl Health, Inc. Common Stock
|
$0.84
|
$194.32M | - | 50 | Compare |
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$16.96
|
$170.45M | - | 59 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$5.10
|
$158.43M | - | 51 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$12.09
|
$133.50M | - | 64 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$22.64
|
$110.20M | - | 60 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$6.75
|
$71.69M | - | 58 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$9.31
|
$67.94M | - | 56 | Compare |
More MGX Analysis
Data updated: Jun 22, 2026 | Industry: Biotechnology (SIC 2836)
221 stocks in this industry